International Stroke Conference presentation highlights clinical results using BrainPath® technology for atraumatic access to emergent brain abnormalities
Nashville, TN — On Thursday, February 12, 2015, the results of a 35 patient, multi-center pilot study spanning a two-year period will be presented to the International Stroke Conference. “The Safety and Efficacy of Image Guided Trans-Sulcal Radial Corridors for Hematoma Evacuation: A Multi-Center Study” will be presented by Dr. Mohamed Labib, a neurosurgeon at the University of Ottawa. Dr. Labib will represent the 10 authors and discuss the “statistically significant” improvement in patients’ neurological state associated with early intervention of hematoma.
Dr. Labib is also a member of the newly formed Subcortical Surgery Group, a growing team of neurosurgeons using new technologies to enable access to deep parts of the brain while preserving essential tissue and structures. In this 10-center study, the BrainPath technology was used as a means of standardizing access to the emergent brain abnormality for early evacuation.
| WHAT: | International Stroke Conference podium presentation: “The Safety and Efficacy of Image Guided Trans-Sulcal Radial Corridors for Hematoma Evacuation: A Multi-Center Study” |
| WHO: | Dr. Mohamed Labib, University of Ottawa |
| DATE: | Thursday, February 12th, 2015 |
| TIME: | 1:30-3:00p.m. EST (estimated presentation time between 2:10-2:40 p.m.) |
| WHERE: | Music City Center, 201 5th Ave. S, Nashville, Tennessee |
Dr. Labib’s presentation will be available to the public following the presentation. For more information, please contact: media@brainpath.com
For more information on the ISC: http://my.americanheart.org/professional/Sessions/InternationalStrokeConference/International-Stroke Conference_UCM_316901_SubHomePage.jsp
For more information on the Subcortical Surgery Group, please contact: info@subcorticalsurgery.com or visit www.subcorticalsurgery.com
About the BrainPath Technology:
The patented BrainPath provides unique atraumatic surgical access to brain abnormalities. It is uniquely designed to minimize tissue damage by displacing tissues of the brain during advancement to the abnormality – much like the way a boat hull moves through water by displacing what is in front of it – all through an opening smaller than a dime. The outer sheath remains in the brain to serve as a protective portal for surgeons to easily maintain access to the surgical site during tissue removal or fluid evacuation.